Defactinib |
Inhibitor of PTK2, PTK2B
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PTK2 |
|
|
| PTK2B |
|
Inhibitor
100 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
Selectivity within target family: Profiling against an Invitrogen panel at 10 µM and 1 µM: Strongest ...
Potency Cellular
In Vitro
PTK2
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1093/jnci/djt210
PTK2B
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1093/jnci/djt210
In Vivo Validations
Rat
Dose: 12.5-50 mg/Kg
Route of delivery:
Intraperitoneal
Plasma half life:
1.0 h
Systemic clearance:
85 mL/min/kg
Fb :
99.72%
Volume of Distribution at Steady-State:
5.0 L/kg
DOI Reference: 10.1093/jnci/djt210
Dog
Dose: 12.5-50 mg/Kg
Route of delivery:
Intraperitoneal
Plasma half life:
2.0 h
Systemic clearance:
12 mL/min/kg
Fb :
99.88%
Volume of Distribution at Steady-State:
2.0 L/Kg
DOI Reference: 10.1093/jnci/djt210
Negative Control Compounds
PF-00911705
Notes: PF-00911705 - Binding IC50 = 721 nM; Two hits in the GPCR scan: GABA/PBR (Ki = 1479.11 nM) and TMEM97 (Ki = 2123.24 nM).
Chemical Information
| Molecular Formula | C20H21F3N8O3S |
| SMILEs | CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1 |
| InChI | InChI=1S/C20H21F3N8O3S/c1-24-18(32)12-4-6-13(7-5-12)29-19-28-10-14(20(21,22)23)16(30-19)27-11-15-17(26-9-8-25-15)31(2)35(3,33)34/h4-10H,11H2,1-3H3,(H,24,32)(H2,27,28,29,30) |
| Molecular weight | 510.14 Da |
| AlogP | 0.0 |
| HBond acceptors | 11 |
| HBond donors | 3 |
| Atoms | 56 |